Recursion Pharmaceuticals Inc - Class A

NEW
NAS:RXRX (USA)   Class A
$ 3.305 -0.035 (-1.05%) 07:08 PM EST
At Loss
P/B:
1.72
Market Cap:
$ 1.76B
Enterprise V:
$ 1.17B
Volume:
19.34M
Avg Vol (2M):
22.68M
Trade In:
Volume:
19.34M
At Loss
Avg Vol (2M):
22.68M

Recursion Pharmaceuticals Inc’s share price is $3.305. Its GF Value is $4.09. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Recursion Pharmaceuticals Inc stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: $3.305 GF Value Price/GF Value
Current $4.09 0.81
Next FY1 End $3.81 0.87
Next 12 Month $4.44 0.74
Next FY2 End $4.9 0.67
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Recursion Pharmaceuticals Inc's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Recursion Pharmaceuticals Inc's stock price and Book Value per share, with a coefficient of 82%. This is followed by a 70% correlation with Earnings without NRI per share. Recursion Pharmaceuticals Inc’s stock price shows no significant correlation with Operating Cash Flow per share. Recursion Pharmaceuticals Inc’s stock price shows no significant correlation with Revenue per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies